Bruna Velosa Ferreira/LinkedIn
Jun 17, 2026, 14:54
Bruna Velosa Ferreira: PV and ET – Beyond Blood Count Control
Bruna Velosa Ferreira, Hematologist at the Champalimaud Clinical Center, shared a post on LinkedIn:
“PV and ET: Beyond Blood Count Control
Three themes that repeatedly emerged across the MPN sessions at EHA2026:
- Disease modification in PV and ET.
- Markers of biological disease activity beyond conventional risk stratification.
- Emerging therapeutic approaches targeting different aspects of MPN biology, including iron metabolism and mutant CALR.
These are exciting developments for the field, and it will be fascinating to follow how these concepts evolve in the coming years.”
Stay updated with Hemostasis Today.
-
Sep 29, 2026, 19:00Caitlin Raymond: Can Artificial Blood Solve Blood Supply Shortages?
-
Sep 29, 2026, 18:51Chaza Alaji: Dyslipidemia, Thrombosis and the DIC Diagnostic Trap
-
Sep 29, 2026, 17:31Rajnikant Patel: Bridging Ayurvedic Concepts and Modern Toxin-Mediated Disease
-
Sep 29, 2026, 17:13Nicholas Lang։ A Meaningful Case of Immune Thrombocytopenia
-
Sep 29, 2026, 16:55Ayatullah Gamal Wahab: When the CBC Lies
-
Sep 29, 2026, 16:35Jonathan Douxfils: Navigating the VTE Risk Continuum in Reproductive Medicine
-
Sep 29, 2026, 16:35Chaima Rajeh: Types of Anemia and Their Laboratory Features
-
Sep 29, 2026, 16:27Scott Isaacs: How GLP-1 RAs Target Systemic Inflammation to Drive Cardio, Autoimmune, and Gut Health
-
Sep 29, 2026, 16:21Yitshak Kreiss: From Treating Patients to Defining the Standard of Knowledge